Sort
130,381 grants matching “hiv”
Structural Biology of HIV Assembly and Maturation
$954,495Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
$954,451Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2018 · DA
Clinical Trials Program
$954,399Timothy J Wilkin · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA
Collaborative Research on Drug Abuse
$954,356Peter M Bentler · University Of California Los Angeles · P01 · FY2007 · DA
Innate Control of SIV-Specific Adaptive Immunity
$954,337Bali Pulendran · Emory University · U19 · FY2015 · AI
Prevalence of PAH in SCD Patients in Nigeria
$954,218Mark Thomas Gladwin · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO)
$954,095Pamina Mae Gorbach · University Of California Los Angeles · U24 · FY2020 · DA
HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY)
$953,985Modupe Coker · University Of Pennsylvania · R01 · FY2025 · DE
Molecular Pathogenesis of Neoplasia
$953,971John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
The Impact of Early Medical Treatment in Transgender Youth
$953,807Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2024 · HD
AIDS International Training and Research Program
$953,630Carey Farquhar · University Of Washington · D43 · FY2007 · TW
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV
$953,504Michael B Zwick · Scripps Research Institute, The · R01 · FY2024 · AI
Core 1: Facility Management, Maintenance and Operations Core
$953,343Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$953,175Maria Grazia Ferrari · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues
$953,109Angela D Kashuba · Univ Of North Carolina Chapel Hill · U01 · FY2012 · AI
Clinical Interventional Studies of HIV Reservoirs
$953,104Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
EXECUTIVE & ADMINISTRATIVE CORES
$953,056Igor Grant · University Of California, San Diego · P01 · FY2008 · DA
Health Promotion and Disease Prevention Research Center
$953,038Tabia Henry-Akintobi · Morehouse School Of Medicine · U48 · FY2016 · DP
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$953,021Wendy S Post · Johns Hopkins University · R01 · FY2012 · HL
2/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
$952,993Kevin J Anstrom · Univ Of North Carolina Chapel Hill · U24 · FY2025 · HL
Role of integrin a4b7 in HIV/SIV transmission across cervico-vaginal mucosa
$952,990Elena Martinelli · Population Council · R56 · FY2017 · AI
Early neonatal treatment and immune quiescence
$952,985Louise Kuhn · Columbia University Health Sciences · U01 · FY2018 · HD
COMMUNITY CONSORTIUM (CPCRA)
$952,983University Of California San Francisco · U01 · FY2000 · AI
PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study
$952,946Sabrina A Assoumou · Boston Medical Center · R01 · FY2023 · DA
Enhancing DNA vaccines using modified Bacterial Toxin A1 Subunits as adjuvants
$952,926Timothy R Fouts · Profectus Biosciences, Inc. · R44 · FY2012 · AI